Plus Therapeutics, Inc.
PSTV
Revenue
703.00k
▼-719.00k▼-50.56%
3 Months ChangeAssets
11.21M
▲5.59M▲99.47%
3 Months ChangeLiabilities
18.84M
▲8.38M▲80.12%
3 Months ChangeFree Cash Flow
-4.55M
▲1.34M▲22.70%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001193125-24-249270
2024-09-06
Form 8-K
ID: 0001193125-24-215218
2024-08-15
Form 8-K
ID: 0001193125-24-201372
2024-08-14
Form 10-Q
ID: 0000950170-24-097091
2024-08-14
Form 8-K
ID: 0000950170-24-097001
2024-06-07
Form 8-K
ID: 0000950170-24-070569
2024-06-04
Form 8-K
ID: 0001193125-24-154380
2024-05-20
Form 8-K
ID: 0000950170-24-062116
2024-05-15
Form 8-K
ID: 0000950170-24-060399
2024-05-15
Form 10-Q
ID: 0000950170-24-060395